These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 3498815

  • 21. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
    Jakowec MW, Nixon K, Hogg E, McNeill T, Petzinger GM.
    J Neurosci Res; 2004 May 15; 76(4):539-50. PubMed ID: 15114626
    [Abstract] [Full Text] [Related]

  • 22. Characterization of hepatic microsomal metabolism as an in vivo detoxication pathway of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Chiba K, Kubota E, Miyakawa T, Kato Y, Ishizaki T.
    J Pharmacol Exp Ther; 1988 Sep 15; 246(3):1108-15. PubMed ID: 3262153
    [Abstract] [Full Text] [Related]

  • 23. Comparison of 1-methyl-4-(p-chlorophenyl)-1,2,3,6-tetrahydropyridine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and p-chloroamphetamine as monoamine depletors.
    Fuller RW, Hemrick-Luecke SK, Robertson DW.
    Res Commun Chem Pathol Pharmacol; 1985 Oct 15; 50(1):57-65. PubMed ID: 2417293
    [Abstract] [Full Text] [Related]

  • 24. Neurotoxicity studies with the monoamine oxidase B substrate 1-methyl-3-phenyl-3-pyrroline.
    Ogunrombi MO, Malan SF, Terre'Blanche G, Castagnoli K, Castagnoli N, Bergh JJ, Petzer JP.
    Life Sci; 2007 Jul 19; 81(6):458-67. PubMed ID: 17655878
    [Abstract] [Full Text] [Related]

  • 25. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.
    Gal S, Zheng H, Fridkin M, Youdim MB.
    J Neurochem; 2005 Oct 19; 95(1):79-88. PubMed ID: 16181414
    [Abstract] [Full Text] [Related]

  • 26. Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice.
    Mori A, Ohashi S, Nakai M, Moriizumi T, Mitsumoto Y.
    Neurosci Res; 2005 Mar 19; 51(3):265-74. PubMed ID: 15710490
    [Abstract] [Full Text] [Related]

  • 27. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
    Leng A, Mura A, Hengerer B, Feldon J, Ferger B.
    Behav Brain Res; 2004 Oct 05; 154(2):375-83. PubMed ID: 15313025
    [Abstract] [Full Text] [Related]

  • 28. Ethylenebisdithiocarbamate enhances MPTP-induced striatal dopamine depletion in mice.
    McGrew DM, Irwin I, Langston JW.
    Neurotoxicology; 2000 Jun 05; 21(3):309-12. PubMed ID: 10894120
    [Abstract] [Full Text] [Related]

  • 29. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
    Fuller RW, Robertson DW, Hemrick-Luecke SK.
    J Pharmacol Exp Ther; 1987 Feb 05; 240(2):415-20. PubMed ID: 3100775
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine.
    Kindt MV, Heikkila RE, Nicklas WJ.
    J Pharmacol Exp Ther; 1987 Sep 05; 242(3):858-63. PubMed ID: 3498818
    [Abstract] [Full Text] [Related]

  • 36. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Fuller RW, Hemrick-Luecke SK.
    J Pharmacol Exp Ther; 1985 Mar 05; 232(3):696-701. PubMed ID: 3871853
    [Abstract] [Full Text] [Related]

  • 37. H MRS identifies lactate rise in the striatum of MPTP-treated C57BL/6 mice.
    Koga K, Mori A, Ohashi S, Kurihara N, Kitagawa H, Ishikawa M, Mitsumoto Y, Nakai M.
    Eur J Neurosci; 2006 Feb 05; 23(4):1077-81. PubMed ID: 16519673
    [Abstract] [Full Text] [Related]

  • 38. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors.
    Heikkila RE, Manzino L, Cabbat FS, Duvoisin RC.
    Nature; 2006 Feb 05; 311(5985):467-9. PubMed ID: 6332989
    [Abstract] [Full Text] [Related]

  • 39. A reactive metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is formed in rat brain in vitro by type B monoamine oxidase.
    Corsini GU, Pintus S, Bocchetta A, Piccardi MP, Del Zompo M.
    J Pharmacol Exp Ther; 1986 Aug 05; 238(2):648-52. PubMed ID: 3488394
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.